NCT06356064

Brief Summary

Objective: The aim of the study was to investigate the effectiveness of radial and focused ESWT treatment on pain, function, and size of the calcaneal spur in patients with a clinical and radiological diagnosis of epin calcanei. Methods: A total of 112 patients aged between 18 and 95 years were randomly divided into two groups: group 1 received rESWT (2.4 bar 12 hz 2000 beats), and group 2 received fESWT (0.14 bar 14 hz 1000 beats) three times a week for three weeks. All patients were evaluated using the Visual Analog Scale (VAS)-pain and Foot Function Index (FFI) before and after the treatment, at 4 weeks and 12 weeks. Epin size was measured radiographically in the patients before and after the treatment at the 12-week follow-up.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
112

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started May 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 15, 2023

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 15, 2023

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

January 15, 2024

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

March 25, 2024

Completed
16 days until next milestone

First Posted

Study publicly available on registry

April 10, 2024

Completed
Last Updated

April 22, 2024

Status Verified

April 1, 2024

Enrollment Period

7 months

First QC Date

March 25, 2024

Last Update Submit

April 18, 2024

Conditions

Outcome Measures

Primary Outcomes (2)

  • Visual Analog Scale

    0 min , 10 is maximum pain score

    Before and after treatment baseline, 4th week, 12 th week

  • Functional Foot Index

    0 is no pain 10 is max pain, and 0 is no deficiency 10 is the maximum deficiency and 0 is no activity limitation 10 is the maximum activity limitation score.

    Before and after treatment baseline, 4th week, 12 th week

Secondary Outcomes (1)

  • Radiographic assesment, epin size

    Before and after treatment baseline, 4th week, 12 th week

Study Arms (2)

rESWT( Radial Extracorporeal shock wave therapy)

EXPERIMENTAL

rESWT(2.4 bar, 12 hz, 2000 beats), to painful calcaneal area, three sessions, once a week, for total of three weeks

Device: Extracorporeal shock wave therapy

fESWT(Focused Extracorporeal shock wave therapy))

EXPERIMENTAL

fESWT (0.14 bar, 14 hz, 1000 beats), to painful calcaneal area, three sessions, once a week, for total of three weeks

Device: Extracorporeal shock wave therapy

Interventions

Radİal ESWT and focus ESWT

fESWT(Focused Extracorporeal shock wave therapy))rESWT( Radial Extracorporeal shock wave therapy)

Eligibility Criteria

Age18 Years - 95 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Presence of heel pain for at least four weeks,
  • Receiving no medical treatment, injection, physical or surgical treatment for the last four weeks and
  • Agreed to participate in the study.

You may not qualify if:

  • History of fracture or surgery,
  • Polyneuropathy,
  • Rheumatological diseases,
  • Coagulation disorders,
  • Tumor,
  • Thrombosis,
  • Soft tissue or bone infection,
  • Pregnancy and lactation,
  • Epilepsy,
  • Presence of a pacemaker.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Özge TEZEN

Ankara, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Heel Spur

Interventions

Extracorporeal Shockwave Therapy

Condition Hierarchy (Ancestors)

ExostosesHyperostosisBone DiseasesMusculoskeletal DiseasesFoot Diseases

Intervention Hierarchy (Ancestors)

Ultrasonic TherapyDiathermyHyperthermia, InducedTherapeuticsPhysical Therapy ModalitiesRehabilitation

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 25, 2024

First Posted

April 10, 2024

Study Start

May 15, 2023

Primary Completion

December 15, 2023

Study Completion

January 15, 2024

Last Updated

April 22, 2024

Record last verified: 2024-04

Data Sharing

IPD Sharing
Will not share

participant data will not share

Locations